Figure S4 from Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma — Javier Martín‐Broto (2023) | RDL Network
Figure S4 from Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma
Preprint 2023 en
Authors
JM
Javier Martín‐Broto
AL
Antonio López–Pousa
AB
Andrew S. Brohl
Abstract
1 min read
<p>Representative pre- and post-olaratumab monotherapy biopsies from the same patient, stained with IHC for PDGFRα (A, B) and PDGFRβ (C, D) and displayed at 200x total magnification. Pre-olaratumab images are A and C; post-treatment images are B and D.</p>
Javier Martín‐Broto, Antonio López–Pousa, Andrew S. Brohl, Brian A. Van Tine, Benjamin Powers, Silvia Stacchiotti, Jean Yves Blay, James Hu, Gerard J. Oakley, Hong Wang, Anna M. Szpurka, Donna E. Levy, Gary Mo, Matteo Ceccarelli, Robin L. Jones
Javier Martín‐Broto, Antonio López–Pousa, Andrew S. Brohl, Brian A. Van Tine, Benjamin Powers, Silvia Stacchiotti, Jean Yves Blay, James Hu, Gerard J. Oakley, Hong Wang, Anna M. Szpurka, Donna E. Levy, Gary Mo, Matteo Ceccarelli, Robin L. Jones
Javier Martín‐Broto, Antonio López–Pousa, Andrew S. Brohl, Brian A. Van Tine, Benjamin Powers, Silvia Stacchiotti, Jean Yves Blay, James Hu, Gerard J. Oakley, Hong Wang, Anna M. Szpurka, Donna E. Levy, Gary Mo, Matteo Ceccarelli, Robin L. Jones
Javier Martín‐Broto, Antonio López–Pousa, Andrew S. Brohl, Brian A. Van Tine, Benjamin Powers, Silvia Stacchiotti, Jean Yves Blay, James Hu, Gerard J. Oakley, Hong Wang, Anna M. Szpurka, Donna E. Levy, Gary Mo, Matteo Ceccarelli, Robin L. Jones
Javier Martín‐Broto, Antonio López–Pousa, Andrew S. Brohl, Brian A. Van Tine, Benjamin Powers, Silvia Stacchiotti, Jean Yves Blay, James Hu, Gerard J. Oakley, Hong Wang, Anna M. Szpurka, Donna E. Levy, Gary Mo, Matteo Ceccarelli, Robin L. Jones
Discussion(0)
No comments yet. Be the first to comment.